Literature DB >> 14709724

A domain of Rad9 specifically required for activation of Chk1 in budding yeast.

Richard T Blankley1, David Lydall.   

Abstract

The Rad9 protein is a key adaptor protein in Saccharomyces cerevisiae DNA damage checkpoint pathways. Its adaptor function is to link the activity of the Mec1 kinase to the activation of two parallel signalling pathways dependent on the Rad53 and Chk1 kinases. The mechanisms by which Rad9 interacts with, and activates, Rad53 are well understood. However, little was known about how Rad9 facilitates the activation of Chk1. We show here that the N-terminus of Rad9 is specifically important for phosphorylation and activation of the Chk1 kinase but not for the phosphorylation and activation of the Rad53 kinase. The Chk1 activation domain (CAD) of Rad9 is specifically important for signalling cell-cycle arrest after cdc13-1- and yku70Delta-induced telomere damage but not for tolerating ultraviolet-induced damage or inhibiting nuclease activity at telomeres. This work extends data showing that separable domains within the Rad9 adaptor protein allow it to activate two distinct kinase signalling pathways independently of each other.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709724     DOI: 10.1242/jcs.00907

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  29 in total

1.  Checkpoint genes and Exo1 regulate nearby inverted repeat fusions that form dicentric chromosomes in Saccharomyces cerevisiae.

Authors:  Salma Kaochar; Lisa Shanks; Ted Weinert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-23       Impact factor: 11.205

Review 2.  Similarities and differences between "uncapped" telomeres and DNA double-strand breaks.

Authors:  James M Dewar; David Lydall
Journal:  Chromosoma       Date:  2011-12-28       Impact factor: 4.316

Review 3.  Eukaryotic DNA damage checkpoint activation in response to double-strand breaks.

Authors:  Karen Finn; Noel Francis Lowndes; Muriel Grenon
Journal:  Cell Mol Life Sci       Date:  2011-11-15       Impact factor: 9.261

4.  Abrogation of the Chk1-Pds1 checkpoint leads to tolerance of persistent single-strand breaks in Saccharomyces cerevisiae.

Authors:  Anandi S Karumbati; Thomas E Wilson
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

Review 5.  Chlamydomonas reinhardtii: a convenient model system for the study of DNA repair in photoautotrophic eukaryotes.

Authors:  Daniel Vlcek; Andrea Sevcovicová; Barbara Sviezená; Eliska Gálová; Eva Miadoková
Journal:  Curr Genet       Date:  2007-11-09       Impact factor: 3.886

6.  Maintenance of the DNA-damage checkpoint requires DNA-damage-induced mediator protein oligomerization.

Authors:  Takehiko Usui; Steven S Foster; John H J Petrini
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

7.  CDC5 inhibits the hyperphosphorylation of the checkpoint kinase Rad53, leading to checkpoint adaptation.

Authors:  Genevieve M Vidanes; Frédéric D Sweeney; Sarah Galicia; Stephanie Cheung; John P Doyle; Daniel Durocher; David P Toczyski
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

8.  Dynamics of Rad9 chromatin binding and checkpoint function are mediated by its dimerization and are cell cycle-regulated by CDK1 activity.

Authors:  Magda Granata; Federico Lazzaro; Daniele Novarina; Davide Panigada; Fabio Puddu; Carla Manuela Abreu; Ramesh Kumar; Muriel Grenon; Noel F Lowndes; Paolo Plevani; Marco Muzi-Falconi
Journal:  PLoS Genet       Date:  2010-08-05       Impact factor: 5.917

9.  S-phase checkpoint pathways stimulate the mobility of the retrovirus-like transposon Ty1.

Authors:  M Joan Curcio; Alison E Kenny; Sharon Moore; David J Garfinkel; Matthew Weintraub; Eric R Gamache; Derek T Scholes
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

Review 10.  Checkpoint Responses to DNA Double-Strand Breaks.

Authors:  David P Waterman; James E Haber; Marcus B Smolka
Journal:  Annu Rev Biochem       Date:  2020-03-16       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.